Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
内质网应激在原发性开角型青光眼发病机制中的作用
基本信息
- 批准号:9039612
- 负责人:
- 金额:$ 24.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-01 至 2018-03-31
- 项目状态:已结题
- 来源:
- 关键词:Advisory CommitteesApoptosisApoptoticAqueous HumorAutophagocytosisAutopsyCell DeathCellsChronicClinicalDataDegradation PathwayDevelopmentDexamethasoneDiagnosisDiseaseEducational process of instructingEndoplasmic ReticulumEyeFailureFunctional disorderGRP78 geneGRP94GeneticGlaucomaHomeostasisHumanIndividualKnockout MiceLaboratoriesLaboratory ResearchLeadLearningLysosomesMentorsModelingMolecular ChaperonesMusMutationNerve DegenerationOcular HypertensionOptic NervePathogenesisPathway interactionsPatientsPhasePhenotypePhenylbutyratesPhosphorylationPhysiologic Intraocular PressurePlayPrimary Open Angle GlaucomaProcessProteinsResearch InstituteResistanceRetinal Ganglion CellsRisk FactorsRoleSirolimusSodium phenylbutyrateSteroidsTestingTissuesTopical applicationTrabecular meshwork structureTrainingTransgenic MiceTransgenic OrganismsWestern Blottingabstractingcareer developmentcommon treatmentendoplasmic reticulum stressexperiencegenetic risk assessmentimprovedinduced pluripotent stem cellinhibitor/antagonistinsightmouse modelmutantmyocilinnovelpreventprotein aggregateprotein degradationprotein misfoldingpublic health relevanceresponsesensorsymposium
项目摘要
Abstract
Primary open angle glaucoma (POAG), the most common form of glaucoma, is usually accompanied by
elevated intraocular pressure (IOP) due to failure of the trabecular meshwork (TM) to maintain normal levels of
aqueous humor outflow. We recently generated a novel transgenic murine model (Tg-MYOCY437H) that
expresses mutant myocilin, a known leading genetic cause of POAG in humans and replicates human
glaucoma phenotypes. Importantly, we have associated endoplasmic reticulum (ER) stress to the
pathogenesis of glaucoma in Tg-MYOCY437H mice. Misfolded myocilin accumulates in the ER, induces ER
stress and activates a protective unfolded protein response (UPR). Along with UPR activation, mutant myocilin
also induces autophagy, a process of lysosomal degradation known to degrade protein aggregates. However,
failure to eliminate myocilin aggregates possibly due to insufficient UPR and impaired autophagy, TM cells
induce the ER stress-initiated apoptotic transcriptional factor, Chop, which may further worsen ER homeostasis
and cause TM dysfunction/loss, elevating IOP and resulting in POAG. The current proposal will further
investigate the role of chronic ER stress in the pathogenesis of myocilin as well as non-myocilin associated
POAG. During the mentored phase, the proposed studies will determine whether failure to activate the
protective UPR (Atf-6�-/-) exacerbates glaucoma phenotypes, whereas interference with ER stress-induced
apoptosis (Chop-/-) prevents glaucoma in Tg-MYOCY437H mice. In addition, we will investigate whether ER
stress is activated in port-mortem TM tissues from POAG donors. During the independent phase, we will
examine whether induction of ER stress in the TM is associated with elevation of IOP in a mouse model of
dexamethasone-induced ocular hypertension. In addition, we will examine the role of autophagy in degradation
of myocilin aggregates and will determine whether inducing autophagy by rapamycin will rescue the glaucoma
of Tg-MYOCY437H mice. Specifically, the candidate will learn and generate new models of ER stress using
Atf6� and Chop knockout mice, generate induced pluripotent stem cells (iPSCs)-derived trabecular meshwork-
like cells from POAG patients, and characterize a dexamethasone-induced ocular hypertension mouse model
in the laboratory of Dr. Val Sheffield. Additionally, during the mentored phase, the candidate will continue his
professional and scientific career development through continual guidance from the advisory committee. He
will attend scientific conferences, and collaborate with ER stress expert, Dr. Thomas Rutkowski and glaucoma
clinical expert, Dr. Lee Alward. He will also acquire teaching experience. This project will facilitate continued
technical, intellectual, and professional training of the candidate, and assist the candidate in the establishment
of an independent research laboratory at an academic research institute.
抽象的
初级开角青光眼(POAG)是青光眼最常见的形式,通常伴随
由于小梁网(TM)失败以维持正常水平,因此眼内压(IOP)升高
水性幽默出口。我们最近生成了一种新型的转基因鼠模型(TG-Myocy437h),该模型是
表达突变体肌动蛋白,这是人类POAG的已知主要遗传原因,并复制人类
青光眼表型。重要的是,我们将内质网(er)应力与
Tg-肌细胞437H小鼠青光眼的发病机理。肌蛋白折叠率折叠在ER中积聚,引起ER
压力并激活受保护的展开的蛋白质反应(UPR)。随着UPR激活,突变体肌动蛋白
还影响自噬,这是一种已知降解蛋白质聚集体的溶酶体降解过程。然而,
无法消除可能是由于UPR不足和自噬受损而导致的肌动蛋白聚集体
诱导ER应力引起的凋亡转录因子CHOP,这可能会进一步稳定稳态
并引起TM功能障碍/损失,升高IOP并导致POAG。当前的提议将进一步
研究慢性ER应激在肌动蛋白以及非肌依肽蛋白的发病机理中的作用
Poag。在修订阶段,提出的研究将确定是否未能激活
保护性UPR(ATF-6。
细胞凋亡(CHOP - / - )可防止TG-Myocy437h小鼠中的青光眼。此外,我们将调查是否
POAG供体的港口验尸TM组织激活了应力。在独立阶段,我们将
检查TM中的ER应力是否与IOP升高有关
地塞米松诱导的眼部高血压。此外,我们将研究自噬在降解中的作用
肌动蛋白骨料的骨料,并将确定雷帕霉素诱导的自噬是否会挽救青光眼
TG-Myocy437h小鼠的。具体而言,候选人将学习并生成新的ER压力模型
ATF6。和CHOP基因敲除小鼠,产生诱导的多能干细胞(IPSC)衍生的小梁网络
像POAG患者的细胞,并表征地塞米松诱导的眼部高血压小鼠模型
在Val Sheffield博士的实验室中。此外,在修补阶段,候选人将继续他的
通过咨询委员会的持续指导,专业和科学的职业发展。他
将参加科学会议,并与ER压力专家Thomas Rutkowski和青光眼合作
临床专家李·阿尔沃德(Lee Alward)博士。他还将获得教学经验。这个项目将有助于继续
候选人的技术,智力和专业培训,并协助候选人建立
一家学术研究所的独立研究实验室。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gulab Zode其他文献
Gulab Zode的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gulab Zode', 18)}}的其他基金
Development and characterization of an inducible model for myocilin POAG
肌纤蛋白 POAG 诱导模型的开发和表征
- 批准号:
10661911 - 财政年份:2023
- 资助金额:
$ 24.86万 - 项目类别:
Targeting ER Stress Pathway Using Sodium 4-Phenylbutyrate for the Treatment of POAG
使用 4-苯基丁酸钠靶向 ER 应激通路治疗 POAG
- 批准号:
10202609 - 财政年份:2018
- 资助金额:
$ 24.86万 - 项目类别:
Targeting ER Stress Pathway Using Sodium 4-Phenylbutyrate for the Treatment of POAG
使用 4-苯基丁酸钠靶向 ER 应激通路治疗 POAG
- 批准号:
9788452 - 财政年份:2018
- 资助金额:
$ 24.86万 - 项目类别:
Crosstalk Between Unfolded Protein Response and Autophagy for the Treatment of Glaucoma
未折叠蛋白反应与自噬之间的串扰用于治疗青光眼
- 批准号:
9124324 - 财政年份:2016
- 资助金额:
$ 24.86万 - 项目类别:
Crosstalk between chronic ER stress and mitophagy for the treatment of POAG
慢性 ER 应激与线粒体自噬治疗 POAG 之间的串扰
- 批准号:
10850091 - 财政年份:2016
- 资助金额:
$ 24.86万 - 项目类别:
Crosstalk between chronic ER stress and mitophagy for the treatment of POAG
慢性 ER 应激与线粒体自噬治疗 POAG 之间的串扰
- 批准号:
10445174 - 财政年份:2016
- 资助金额:
$ 24.86万 - 项目类别:
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
内质网应激在原发性开角型青光眼发病机制中的作用
- 批准号:
8822297 - 财政年份:2014
- 资助金额:
$ 24.86万 - 项目类别:
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
内质网应激在原发性开角型青光眼发病机制中的作用
- 批准号:
8813843 - 财政年份:2014
- 资助金额:
$ 24.86万 - 项目类别:
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
内质网应激在原发性开角型青光眼发病机制中的作用
- 批准号:
8383990 - 财政年份:2012
- 资助金额:
$ 24.86万 - 项目类别:
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
内质网应激在原发性开角型青光眼发病机制中的作用
- 批准号:
8534133 - 财政年份:2012
- 资助金额:
$ 24.86万 - 项目类别:
相似国自然基金
基于巨噬细胞表型转变探讨BTSA1诱导衰老肌成纤维细胞凋亡及促肺纤维化消退的机制
- 批准号:82370077
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
STAB1调控Fas/FasL介导牦牛胎盘滋养层细胞凋亡及胎盘炎症性流产的作用与机制研究
- 批准号:32360836
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
ATAD3A琥珀酰化调控mtDNA损伤-泛凋亡反应轴在心梗后心衰中的作用研究
- 批准号:82300434
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
胸腺肽α-1介导凋亡小体RNA改善DC功能增强TNBC化疗后抗肿瘤免疫应答的机制研究
- 批准号:82303959
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
LSD1通过使组蛋白H3K4位点去甲基化促进自噬参与肾小管上皮细胞凋亡和肾脏纤维化的机制研究
- 批准号:82300769
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Prohibiting Cell Death in Human Keratocytes: New Insights for Non-surgical Keratoconus Treatment
抑制人角膜细胞的细胞死亡:非手术圆锥角膜治疗的新见解
- 批准号:
10720431 - 财政年份:2023
- 资助金额:
$ 24.86万 - 项目类别:
Nuclear and chromatin aberrations during non-apoptotic cell death in C. elegans and mammals
线虫和哺乳动物非凋亡细胞死亡过程中的核和染色质畸变
- 批准号:
10723868 - 财政年份:2023
- 资助金额:
$ 24.86万 - 项目类别:
Beta Cell Heterogeneity in the Interferon Alpha Response
干扰素α反应中的β细胞异质性
- 批准号:
10751684 - 财政年份:2023
- 资助金额:
$ 24.86万 - 项目类别:
Elucidating Critical Dependencies Underlying Therapeutic Evasion in Philadelphia Chromosome-like Acute Lymphoblastic Leukemia
阐明费城染色体样急性淋巴细胞白血病治疗逃避背后的关键依赖性
- 批准号:
10507298 - 财政年份:2022
- 资助金额:
$ 24.86万 - 项目类别:
Paxillin and Androgens in the Regulation of Ovarian Follicle Development
桩蛋白和雄激素在卵巢卵泡发育调节中的作用
- 批准号:
10688086 - 财政年份:2022
- 资助金额:
$ 24.86万 - 项目类别: